Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, October 2009, p. 4537-4539, Vol. 53, No. 10
0066-4804/09/$08.00+0 doi:10.1128/AAC.00785-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Department of Pathology, Hershey Medical Center, Hershey, Pennsylvania 17033
Received 12 June 2009/ Returned for modification 12 July 2009/ Accepted 8 August 2009
The postantibiotic effects (PAEs), postantibiotic sub-MIC effects (PA-SMEs), and sub-MIC effects (SMEs) of ceftaroline, a novel injectable cephalosporin, were determined for 15 gram-positive organisms. The pneumococcal, staphylococcal, and enterococcal PAEs were 0.8 to 1.8 h, 0.7 to 2.2 h, and 0.2 to 1.1 h, respectively. The corresponding PA-SMEs (0.4 times the MIC) were 2.5 to 6.7 h, 2.9 to >0.0 h, and 7.9 to >10.3 h, respectively. The PA-SMEs were longer than the PAEs, suggesting that sub-MIC levels extend the PAE of ceftaroline against gram-positive cocci.
Published ahead of print on 21 September 2009.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»